Healthy volunteers help validate new blood tests for cancer detection
NCT ID NCT07663994
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study enrolls 68 healthy volunteers (cancer-free adults working at a French hospital) to help validate new blood-based DNA analysis methods. Participants give one blood sample, which is tested for cancer-related genetic mutations using advanced sequencing and PCR techniques. The goal is to confirm that these tests correctly identify people without cancer, laying groundwork for future early detection tools.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help develop more accurate blood tests to detect cancer early in healthy people.
What could go wrong
This is a small, early-stage validation study in healthy volunteers, not a treatment trial. The methods may not prove reliable enough for widespread use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS (CANCER) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Institut Universitaire du Cancer de Toulouse - Oncopole
RECRUITINGToulouse, 31059, France
Contact Phone: •••-•••-•••• Email: •••••@•••••